Drugs / Gonadorelin (GnRH)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01894581 | Jul → Dec 2014 | infertility disorder, obesity disorder | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gonadorelin (GnRH) | “Gonadorelin (GnRH)” NCT01894581 ↗ |
| Known as | GnRH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01894581 ↗ |
| Route | Intravenous | “An intravenous bolus of exogenous GnRH (75 ng/kg dosing based on total body weight) will be administered at 6 hours.” NCT01894581 ↗ |